| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1240.3 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 2159.01 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1683.9 | 97 |
| GSM780719 | Untreated after 4 days (C1_2) | 1307.76 | 97 |
| GSM780720 | Untreated after 4 days (C2_2) | 1693.07 | 97 |
| GSM780721 | Untreated after 4 days (C3_2) | 1646.48 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2427.03 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2329.34 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2629.57 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 3123.33 | 99 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1949.83 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2085.74 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1118.7 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2062.46 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1490.9 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1081.81 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1826.34 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1595.58 | 97 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 3717.55 | 99 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 4434.96 | 99 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 3053.99 | 99 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 4160.09 | 99 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 3390.05 | 99 |